» Articles » PMID: 33416981

6-Shogaol from Ginger Shows Anti-tumor Effect in Cervical Carcinoma Via PI3K/Akt/mTOR Pathway

Overview
Journal Eur J Nutr
Date 2021 Jan 8
PMID 33416981
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: 6-Shogaol, an active phenolic compound from ginger (Zingiber officinale), can inhibit the growth of a variety of human cancer cells. Nevertheless, its underlying molecular mechanisms in cervical cancer remain unclear. In this study, we systematically examine the inhibitory effect of 6-shogaol on cervical cancer in vitro and in vivo.

Methods: Cell proliferation was assessed by CCK8 assay and colony formation assay in HeLa and SiHa cells. We analyzed cell cycle and apoptosis through flow cytometry. GFP-LC3 puncta and transmission electron microscopy were used to observe autophagic bodies. Wound-healing assay and transwell assay were used for evaluating the migration of cells. Western blot was applied to detect protein expression levels.

Results: 6-Shogaol could suppress cell proliferation and migration, cause cell cycle arrest in the G2/M phase in HeLa and SiHa cells. Moreover, 6-shogaol triggered the apoptosis process through the mitochondrial pathway by downregulating the expression levels of p-PI3K, p-Akt and p-mTOR. Further research indicated that the induction of apoptosis by 6-shogaol was remarkably decreased after the treatment of ROS scavenger and PI3K agonist. Additionally, 6-shogaol increased the number of LC3-positive puncta and autophagic bodies per cell in both HeLa and SiHa cells. Pretreatment of cells with Bafilomycin A1, an autophagy inhibitor, accelerated 6-shogaol mediated cell apoptosis, suggesting that induction of autophagy by 6-shogaol is suppressive to apoptosis. Furthermore, in vivo data revealed that 6-shogaol significantly inhibited tumor growth and cell proliferation in tumor tissues.

Conclusion: These findings suggested that 6-shogaol could be developed as a functional food ingredient, which is potentially used as therapeutic agents for patients with cervical cancer.

Citing Articles

Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer.

Guo Z, Li G, Shen L, Pan J, Dou D, Gong Y Int J Nanomedicine. 2025; 20:1147-1169.

PMID: 39902066 PMC: 11789776. DOI: 10.2147/IJN.S478435.


A novel sensitizer reduces EGFR-TKI resistance by regulating the PI3K/Akt/mTOR pathway and autophagy.

Zhang J, Qu Z, Xiao X, Adelson D, Wang F, Wei A Heliyon. 2025; 11(1):e41104.

PMID: 39844968 PMC: 11750466. DOI: 10.1016/j.heliyon.2024.e41104.


Incredible use of plant-derived bioactives as anticancer agents.

Kangra K, Kakkar S, Mittal V, Kumar V, Aggarwal N, Chopra H RSC Adv. 2025; 15(3):1721-1746.

PMID: 39835210 PMC: 11744461. DOI: 10.1039/d4ra05089d.


Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review.

Abdull Rahim U, Mustapa M, Mohamed Shakrin N, Nurdin A, Mohamad Taridi N, Mohd Yusof Y PLoS One. 2024; 19(11):e0314280.

PMID: 39576841 PMC: 11584093. DOI: 10.1371/journal.pone.0314280.


The Role and Function of Secretory Protein Matrix Metalloproteinase-3 () in Cervical Cancer.

Shao L, Liu W, Zhang C, Ma W, Yu X, Han J Iran J Public Health. 2024; 53(4):855-866.

PMID: 39444485 PMC: 11493579. DOI: 10.18502/ijph.v53i4.15562.


References
1.
Chrysostomou A, Stylianou D, Constantinidou A, Kostrikis L . Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018; 10(12). PMC: 6315375. DOI: 10.3390/v10120729. View

2.
Li H, Wu X, Cheng X . Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016; 27(4):e43. PMC: 4864519. DOI: 10.3802/jgo.2016.27.e43. View

3.
Mrklas K, MacDonald S, Shea-Budgell M, Bedingfield N, Ganshorn H, Glaze S . Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol. Syst Rev. 2018; 7(1):40. PMC: 5833130. DOI: 10.1186/s13643-018-0692-y. View

4.
Ali B, Blunden G, Tanira M, Nemmar A . Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2007; 46(2):409-20. DOI: 10.1016/j.fct.2007.09.085. View

5.
Lantz R, Chen G, Sarihan M, Solyom A, Jolad S, Timmermann B . The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2006; 14(2-3):123-8. DOI: 10.1016/j.phymed.2006.03.003. View